| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10:54 | Samsung Bioepis, Teva partner on biosimilar candidates | ||
| 10:54 | Hercules announces CFO succession as Wheatcroft retires | ||
| 10:54 | Marechale Capital schedules AGM for Oct. 26 in London | ||
| 10:54 | BMO Capital downgrades Sigma Lithium stock rating on legal concerns | ||
| 10:54 | Oppenheimer initiates Vita Coco stock coverage with outperform rating | ||
| 10:54 | Barclays reinstates Williams Companies stock rating at overweight | ||
| 10:30 | Persimmon issues 37,736 shares for employee schemes | ||
| 10:30 | Rothschild Redburn downgrades Hermes stock rating on China concerns | ||
| 10:18 | Grande Portage secures gold offtake deal with Ocean Partners | ||
| 10:18 | Thungela executives receive dividend equivalent shares | ||
| 10:18 | Kaufman & Broad 9M 2026 slides: margins hold amid French housing slump | ||
| 10:18 | KeyBanc reiterates Micron Technology stock rating on strong demand | ||
| 10:18 | Wedbush reiterates Micron stock rating on tight supply outlook | ||
| 10:18 | Rosenblatt raises Micron stock price target on margin outlook | ||
| 10:18 | BMO reiterates Micron stock rating on strong demand outlook | ||
| 09:54 | Arqiva appoints Simon Duffy as board chair | ||
| 09:54 | Mizuho raises Micron stock price target to $1,400 on AI strength | ||
| 09:54 | Raymond James reiterates Micron stock rating on strong demand outlook | ||
| 09:54 | Melius reiterates Micron stock Buy rating on tighter supply outlook | ||
| 09:54 | RBC Capital reiterates Micron stock rating on supply outlook | ||
| 09:54 | Barclays initiates Amrize stock with Equalweight rating | ||
| 09:54 | Roth/MKM initiates Civeo stock with buy rating on valuation gap | ||
| 09:54 | JPMorgan initiates Spyre stock with Overweight on IBD pipeline | ||
| 09:54 | JPMorgan initiates Kura Oncology stock with overweight rating | ||
| 09:54 | Enliven Therapeutics stock initiated at Overweight by JPMorgan |